Stereotactic body radiation therapy for prostate cancer: systematic review and meta-analysis of prospective trials
PDF | Full Text | Supplementary Files | How to cite
Metrics: PDF 865 views | Full Text 1387 views | ?
Taylor R. Cushman1, Vivek Verma2, Rahul Khairnar3, Joseph Levy3, Charles B. Simone 2nd4 and Mark V. Mishra4
1 Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
2 Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA, USA
3 Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
4 Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA
|Vivek Verma,||email:||[email protected]|
Keywords: prostate cancer; stereotactic body radiation therapy; stereotactic ablative radiation therapy; hypofractionation; toxicities
Received: April 17, 2019 Accepted: August 05, 2019 Published: September 24, 2019
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.